nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A1—obesity	0.217	1	CbGaD
Disopyramide—ORM1—Bupropion—obesity	0.0757	0.293	CbGbCtD
Disopyramide—Isopropamide—Benzphetamine—obesity	0.0541	0.156	CrCrCtD
Disopyramide—SLC22A2—Cimetidine—obesity	0.046	0.178	CbGbCtD
Disopyramide—Levomethadyl Acetate—Benzphetamine—obesity	0.0453	0.131	CrCrCtD
Disopyramide—Methadyl Acetate—Benzphetamine—obesity	0.0453	0.131	CrCrCtD
Disopyramide—SLC22A1—Cimetidine—obesity	0.0399	0.154	CbGbCtD
Disopyramide—SCN5A—Topiramate—obesity	0.0395	0.153	CbGbCtD
Disopyramide—Doxylamine—Benzphetamine—obesity	0.0391	0.113	CrCrCtD
Disopyramide—Dextropropoxyphene—Benzphetamine—obesity	0.0371	0.107	CrCrCtD
Disopyramide—Tripelennamine—Benzphetamine—obesity	0.0354	0.102	CrCrCtD
Disopyramide—Pheniramine—Benzphetamine—obesity	0.0324	0.0934	CrCrCtD
Disopyramide—Methadone—Benzphetamine—obesity	0.0311	0.0896	CrCrCtD
Disopyramide—Clofedanol—Benzphetamine—obesity	0.0269	0.0775	CrCrCtD
Disopyramide—CYP3A4—Sibutramine—obesity	0.0155	0.0599	CbGbCtD
Disopyramide—CYP3A4—Benzphetamine—obesity	0.0117	0.0454	CbGbCtD
Disopyramide—CYP3A4—Bupropion—obesity	0.00999	0.0386	CbGbCtD
Disopyramide—CYP3A4—Orlistat—obesity	0.00814	0.0315	CbGbCtD
Disopyramide—CYP3A4—Cimetidine—obesity	0.00733	0.0283	CbGbCtD
Disopyramide—CYP3A4—Topiramate—obesity	0.0048	0.0186	CbGbCtD
Disopyramide—ORM1—bile—obesity	0.00389	0.141	CbGeAlD
Disopyramide—CHRM3—muscle of abdomen—obesity	0.00356	0.129	CbGeAlD
Disopyramide—KCND2—hindbrain—obesity	0.00229	0.0831	CbGeAlD
Disopyramide—KCND3—hindbrain—obesity	0.002	0.0724	CbGeAlD
Disopyramide—KCND3—islet of Langerhans—obesity	0.00129	0.0469	CbGeAlD
Disopyramide—KCND3—respiratory system—obesity	0.00122	0.0442	CbGeAlD
Disopyramide—ORM1—gall bladder—obesity	0.00108	0.0392	CbGeAlD
Disopyramide—KCND2—cardiovascular system—obesity	0.00107	0.0389	CbGeAlD
Disopyramide—KCND2—pituitary gland—obesity	0.000948	0.0344	CbGeAlD
Disopyramide—KCND2—adipose tissue—obesity	0.000944	0.0343	CbGeAlD
Disopyramide—KCND3—cardiovascular system—obesity	0.000934	0.0339	CbGeAlD
Disopyramide—KCND3—adipose tissue—obesity	0.000823	0.0299	CbGeAlD
Disopyramide—KCND3—adrenal gland—obesity	0.000739	0.0268	CbGeAlD
Disopyramide—KCND3—liver—obesity	0.000577	0.021	CbGeAlD
Disopyramide—SCN5A—cardiovascular system—obesity	0.000561	0.0203	CbGeAlD
Disopyramide—SLC22A2—digestive system—obesity	0.000551	0.02	CbGeAlD
Disopyramide—CHRM2—cardiovascular system—obesity	0.000477	0.0173	CbGeAlD
Disopyramide—SCN5A—digestive system—obesity	0.000465	0.0169	CbGeAlD
Disopyramide—CHRM1—cardiovascular system—obesity	0.000434	0.0158	CbGeAlD
Disopyramide—SLC22A1—adipose tissue—obesity	0.000413	0.015	CbGeAlD
Disopyramide—ORM1—endocrine gland—obesity	0.000351	0.0127	CbGeAlD
Disopyramide—CHRM3—adipose tissue—obesity	0.000343	0.0124	CbGeAlD
Disopyramide—CHRM2—endocrine gland—obesity	0.000327	0.0119	CbGeAlD
Disopyramide—CHRM3—digestive system—obesity	0.000323	0.0117	CbGeAlD
Disopyramide—SLC22A1—endocrine gland—obesity	0.000322	0.0117	CbGeAlD
Disopyramide—ORM1—liver—obesity	0.000316	0.0115	CbGeAlD
Disopyramide—CHRM1—endocrine gland—obesity	0.000298	0.0108	CbGeAlD
Disopyramide—SLC22A1—liver—obesity	0.00029	0.0105	CbGeAlD
Disopyramide—CHRM3—endocrine gland—obesity	0.000267	0.00968	CbGeAlD
Disopyramide—Insomnia—Diethylpropion—obesity	0.000251	0.00277	CcSEcCtD
Disopyramide—Diplopia—Bupropion—obesity	0.00025	0.00277	CcSEcCtD
Disopyramide—Abdominal distension—Sibutramine—obesity	0.00025	0.00276	CcSEcCtD
Disopyramide—Sweating increased—Orlistat—obesity	0.00025	0.00276	CcSEcCtD
Disopyramide—Dyspnoea—Diethylpropion—obesity	0.000247	0.00273	CcSEcCtD
Disopyramide—Somnolence—Diethylpropion—obesity	0.000247	0.00273	CcSEcCtD
Disopyramide—Headache—Phendimetrazine—obesity	0.000244	0.0027	CcSEcCtD
Disopyramide—Psychotic disorder—Bupropion—obesity	0.000244	0.0027	CcSEcCtD
Disopyramide—Dyspepsia—Diethylpropion—obesity	0.000244	0.0027	CcSEcCtD
Disopyramide—Urinary retention—Bupropion—obesity	0.000238	0.00263	CcSEcCtD
Disopyramide—Constipation—Diethylpropion—obesity	0.000237	0.00262	CcSEcCtD
Disopyramide—Somnolence—Cimetidine—obesity	0.000235	0.00259	CcSEcCtD
Disopyramide—Hepatic enzyme increased—Topiramate—obesity	0.000232	0.00257	CcSEcCtD
Disopyramide—Dysuria—Sibutramine—obesity	0.000232	0.00256	CcSEcCtD
Disopyramide—Nausea—Phendimetrazine—obesity	0.000232	0.00256	CcSEcCtD
Disopyramide—Creatinine increased—Topiramate—obesity	0.000231	0.00255	CcSEcCtD
Disopyramide—Pollakiuria—Sibutramine—obesity	0.000229	0.00253	CcSEcCtD
Disopyramide—Asthenia—Phentermine—obesity	0.000229	0.00253	CcSEcCtD
Disopyramide—Feeling abnormal—Diethylpropion—obesity	0.000229	0.00253	CcSEcCtD
Disopyramide—Abdominal pain upper—Bupropion—obesity	0.000229	0.00253	CcSEcCtD
Disopyramide—Erectile dysfunction—Sibutramine—obesity	0.000229	0.00253	CcSEcCtD
Disopyramide—Depression—Orlistat—obesity	0.000228	0.00252	CcSEcCtD
Disopyramide—Fatigue—Cimetidine—obesity	0.000228	0.00252	CcSEcCtD
Disopyramide—Atrioventricular block—Topiramate—obesity	0.000226	0.0025	CcSEcCtD
Disopyramide—Constipation—Cimetidine—obesity	0.000226	0.0025	CcSEcCtD
Disopyramide—Weight increased—Sibutramine—obesity	0.000226	0.0025	CcSEcCtD
Disopyramide—Muscular weakness—Bupropion—obesity	0.000221	0.00244	CcSEcCtD
Disopyramide—Depression—Sibutramine—obesity	0.000221	0.00244	CcSEcCtD
Disopyramide—Urticaria—Diethylpropion—obesity	0.00022	0.00244	CcSEcCtD
Disopyramide—Dizziness—Phenylpropanolamine—obesity	0.00022	0.00244	CcSEcCtD
Disopyramide—Diarrhoea—Phentermine—obesity	0.000218	0.00241	CcSEcCtD
Disopyramide—Abdominal distension—Bupropion—obesity	0.000218	0.00241	CcSEcCtD
Disopyramide—Feeling abnormal—Cimetidine—obesity	0.000218	0.00241	CcSEcCtD
Disopyramide—Vomiting—Phenylpropanolamine—obesity	0.000212	0.00234	CcSEcCtD
Disopyramide—Dizziness—Phentermine—obesity	0.000211	0.00233	CcSEcCtD
Disopyramide—Sweating increased—Bupropion—obesity	0.000211	0.00233	CcSEcCtD
Disopyramide—Rash—Phenylpropanolamine—obesity	0.00021	0.00232	CcSEcCtD
Disopyramide—Dermatitis—Phenylpropanolamine—obesity	0.00021	0.00232	CcSEcCtD
Disopyramide—Body temperature increased—Cimetidine—obesity	0.000209	0.00231	CcSEcCtD
Disopyramide—Hepatitis—Orlistat—obesity	0.000205	0.00227	CcSEcCtD
Disopyramide—Dry eye—Topiramate—obesity	0.000203	0.00224	CcSEcCtD
Disopyramide—Vomiting—Phentermine—obesity	0.000203	0.00224	CcSEcCtD
Disopyramide—Dysuria—Bupropion—obesity	0.000202	0.00224	CcSEcCtD
Disopyramide—Bradycardia—Sibutramine—obesity	0.000202	0.00223	CcSEcCtD
Disopyramide—Rash—Phentermine—obesity	0.000201	0.00222	CcSEcCtD
Disopyramide—Dermatitis—Phentermine—obesity	0.000201	0.00222	CcSEcCtD
Disopyramide—Headache—Phentermine—obesity	0.0002	0.00221	CcSEcCtD
Disopyramide—Pollakiuria—Bupropion—obesity	0.0002	0.00221	CcSEcCtD
Disopyramide—Erectile dysfunction—Bupropion—obesity	0.000199	0.0022	CcSEcCtD
Disopyramide—Nausea—Phenylpropanolamine—obesity	0.000198	0.00219	CcSEcCtD
Disopyramide—Hypoaesthesia—Sibutramine—obesity	0.000198	0.00218	CcSEcCtD
Disopyramide—Weight increased—Bupropion—obesity	0.000197	0.00218	CcSEcCtD
Disopyramide—Diarrhoea—Diethylpropion—obesity	0.00019	0.0021	CcSEcCtD
Disopyramide—Nausea—Phentermine—obesity	0.000189	0.00209	CcSEcCtD
Disopyramide—Asthenia—Cimetidine—obesity	0.000189	0.00209	CcSEcCtD
Disopyramide—Dizziness—Diethylpropion—obesity	0.000184	0.00203	CcSEcCtD
Disopyramide—Diarrhoea—Cimetidine—obesity	0.000181	0.002	CcSEcCtD
Disopyramide—Arrhythmia—Sibutramine—obesity	0.000177	0.00196	CcSEcCtD
Disopyramide—CYP3A4—digestive system—obesity	0.000177	0.00643	CbGeAlD
Disopyramide—Vomiting—Diethylpropion—obesity	0.000176	0.00195	CcSEcCtD
Disopyramide—Flatulence—Orlistat—obesity	0.000176	0.00195	CcSEcCtD
Disopyramide—Rash—Diethylpropion—obesity	0.000175	0.00193	CcSEcCtD
Disopyramide—Dysgeusia—Orlistat—obesity	0.000175	0.00193	CcSEcCtD
Disopyramide—Dermatitis—Diethylpropion—obesity	0.000175	0.00193	CcSEcCtD
Disopyramide—Dizziness—Cimetidine—obesity	0.000175	0.00193	CcSEcCtD
Disopyramide—Headache—Diethylpropion—obesity	0.000174	0.00192	CcSEcCtD
Disopyramide—Hepatitis—Bupropion—obesity	0.000173	0.00191	CcSEcCtD
Disopyramide—Hypoaesthesia—Bupropion—obesity	0.000172	0.0019	CcSEcCtD
Disopyramide—Flatulence—Sibutramine—obesity	0.00017	0.00188	CcSEcCtD
Disopyramide—Tension—Sibutramine—obesity	0.00017	0.00188	CcSEcCtD
Disopyramide—Dysgeusia—Sibutramine—obesity	0.000169	0.00187	CcSEcCtD
Disopyramide—Vision blurred—Orlistat—obesity	0.000168	0.00186	CcSEcCtD
Disopyramide—Nervousness—Sibutramine—obesity	0.000168	0.00186	CcSEcCtD
Disopyramide—Vomiting—Cimetidine—obesity	0.000168	0.00186	CcSEcCtD
Disopyramide—Rash—Cimetidine—obesity	0.000167	0.00184	CcSEcCtD
Disopyramide—Dermatitis—Cimetidine—obesity	0.000166	0.00184	CcSEcCtD
Disopyramide—Ill-defined disorder—Orlistat—obesity	0.000166	0.00183	CcSEcCtD
Disopyramide—Headache—Cimetidine—obesity	0.000165	0.00183	CcSEcCtD
Disopyramide—Nausea—Diethylpropion—obesity	0.000165	0.00182	CcSEcCtD
Disopyramide—Hypoglycaemia—Topiramate—obesity	0.000163	0.00181	CcSEcCtD
Disopyramide—Angioedema—Orlistat—obesity	0.000163	0.0018	CcSEcCtD
Disopyramide—Vision blurred—Sibutramine—obesity	0.000163	0.0018	CcSEcCtD
Disopyramide—Malaise—Orlistat—obesity	0.000161	0.00178	CcSEcCtD
Disopyramide—Vertigo—Orlistat—obesity	0.00016	0.00177	CcSEcCtD
Disopyramide—Ill-defined disorder—Sibutramine—obesity	0.00016	0.00177	CcSEcCtD
Disopyramide—Diplopia—Topiramate—obesity	0.000159	0.00176	CcSEcCtD
Disopyramide—Angioedema—Sibutramine—obesity	0.000158	0.00175	CcSEcCtD
Disopyramide—Nausea—Cimetidine—obesity	0.000157	0.00173	CcSEcCtD
Disopyramide—Malaise—Sibutramine—obesity	0.000156	0.00172	CcSEcCtD
Disopyramide—Psychotic disorder—Topiramate—obesity	0.000156	0.00172	CcSEcCtD
Disopyramide—Vertigo—Sibutramine—obesity	0.000155	0.00172	CcSEcCtD
Disopyramide—Syncope—Sibutramine—obesity	0.000155	0.00171	CcSEcCtD
Disopyramide—Arrhythmia—Bupropion—obesity	0.000155	0.00171	CcSEcCtD
Disopyramide—Chest pain—Orlistat—obesity	0.000152	0.00168	CcSEcCtD
Disopyramide—Loss of consciousness—Sibutramine—obesity	0.000152	0.00168	CcSEcCtD
Disopyramide—Urinary retention—Topiramate—obesity	0.000152	0.00168	CcSEcCtD
Disopyramide—Discomfort—Orlistat—obesity	0.00015	0.00166	CcSEcCtD
Disopyramide—Blood creatinine increased—Topiramate—obesity	0.000149	0.00165	CcSEcCtD
Disopyramide—Dry mouth—Orlistat—obesity	0.000149	0.00164	CcSEcCtD
Disopyramide—Flatulence—Bupropion—obesity	0.000149	0.00164	CcSEcCtD
Disopyramide—Tension—Bupropion—obesity	0.000148	0.00163	CcSEcCtD
Disopyramide—Dysgeusia—Bupropion—obesity	0.000148	0.00163	CcSEcCtD
Disopyramide—Chest pain—Sibutramine—obesity	0.000147	0.00163	CcSEcCtD
Disopyramide—CYP3A4—endocrine gland—obesity	0.000147	0.00532	CbGeAlD
Disopyramide—Nervousness—Bupropion—obesity	0.000146	0.00162	CcSEcCtD
Disopyramide—Oedema—Orlistat—obesity	0.000146	0.00161	CcSEcCtD
Disopyramide—Abdominal pain upper—Topiramate—obesity	0.000146	0.00161	CcSEcCtD
Disopyramide—Discomfort—Sibutramine—obesity	0.000145	0.00161	CcSEcCtD
Disopyramide—Hypokalaemia—Topiramate—obesity	0.000145	0.0016	CcSEcCtD
Disopyramide—Dry mouth—Sibutramine—obesity	0.000144	0.00159	CcSEcCtD
Disopyramide—Confusional state—Sibutramine—obesity	0.000142	0.00157	CcSEcCtD
Disopyramide—Vision blurred—Bupropion—obesity	0.000142	0.00157	CcSEcCtD
Disopyramide—Skin disorder—Orlistat—obesity	0.000142	0.00157	CcSEcCtD
Disopyramide—Oedema—Sibutramine—obesity	0.000141	0.00156	CcSEcCtD
Disopyramide—Hyperhidrosis—Orlistat—obesity	0.000141	0.00156	CcSEcCtD
Disopyramide—Muscular weakness—Topiramate—obesity	0.000141	0.00155	CcSEcCtD
Disopyramide—Ill-defined disorder—Bupropion—obesity	0.00014	0.00155	CcSEcCtD
Disopyramide—Shock—Sibutramine—obesity	0.000139	0.00153	CcSEcCtD
Disopyramide—Abdominal distension—Topiramate—obesity	0.000139	0.00153	CcSEcCtD
Disopyramide—Thrombocytopenia—Sibutramine—obesity	0.000138	0.00153	CcSEcCtD
Disopyramide—Angioedema—Bupropion—obesity	0.000138	0.00152	CcSEcCtD
Disopyramide—Skin disorder—Sibutramine—obesity	0.000137	0.00151	CcSEcCtD
Disopyramide—Hyperhidrosis—Sibutramine—obesity	0.000136	0.00151	CcSEcCtD
Disopyramide—Malaise—Bupropion—obesity	0.000136	0.0015	CcSEcCtD
Disopyramide—Vertigo—Bupropion—obesity	0.000135	0.0015	CcSEcCtD
Disopyramide—Syncope—Bupropion—obesity	0.000135	0.00149	CcSEcCtD
Disopyramide—Anorexia—Sibutramine—obesity	0.000134	0.00149	CcSEcCtD
Disopyramide—Sweating increased—Topiramate—obesity	0.000134	0.00148	CcSEcCtD
Disopyramide—Loss of consciousness—Bupropion—obesity	0.000132	0.00146	CcSEcCtD
Disopyramide—CYP3A4—liver—obesity	0.000132	0.00479	CbGeAlD
Disopyramide—Insomnia—Orlistat—obesity	0.000132	0.00146	CcSEcCtD
Disopyramide—Hypotension—Sibutramine—obesity	0.000132	0.00146	CcSEcCtD
Disopyramide—Paraesthesia—Orlistat—obesity	0.000131	0.00145	CcSEcCtD
Disopyramide—Dysuria—Topiramate—obesity	0.000129	0.00142	CcSEcCtD
Disopyramide—Neutropenia—Topiramate—obesity	0.000129	0.00142	CcSEcCtD
Disopyramide—Dyspepsia—Orlistat—obesity	0.000128	0.00142	CcSEcCtD
Disopyramide—Chest pain—Bupropion—obesity	0.000128	0.00142	CcSEcCtD
Disopyramide—Insomnia—Sibutramine—obesity	0.000128	0.00141	CcSEcCtD
Disopyramide—Pollakiuria—Topiramate—obesity	0.000127	0.00141	CcSEcCtD
Disopyramide—Erectile dysfunction—Topiramate—obesity	0.000127	0.0014	CcSEcCtD
Disopyramide—Discomfort—Bupropion—obesity	0.000127	0.0014	CcSEcCtD
Disopyramide—Decreased appetite—Orlistat—obesity	0.000127	0.0014	CcSEcCtD
Disopyramide—Paraesthesia—Sibutramine—obesity	0.000127	0.0014	CcSEcCtD
Disopyramide—Dyspnoea—Sibutramine—obesity	0.000126	0.00139	CcSEcCtD
Disopyramide—Fatigue—Orlistat—obesity	0.000126	0.00139	CcSEcCtD
Disopyramide—Dry mouth—Bupropion—obesity	0.000125	0.00139	CcSEcCtD
Disopyramide—Somnolence—Sibutramine—obesity	0.000125	0.00139	CcSEcCtD
Disopyramide—Weight increased—Topiramate—obesity	0.000125	0.00139	CcSEcCtD
Disopyramide—Pain—Orlistat—obesity	0.000125	0.00138	CcSEcCtD
Disopyramide—Dyspepsia—Sibutramine—obesity	0.000124	0.00137	CcSEcCtD
Disopyramide—Confusional state—Bupropion—obesity	0.000124	0.00137	CcSEcCtD
Disopyramide—Oedema—Bupropion—obesity	0.000123	0.00136	CcSEcCtD
Disopyramide—Decreased appetite—Sibutramine—obesity	0.000123	0.00136	CcSEcCtD
Disopyramide—Depression—Topiramate—obesity	0.000123	0.00135	CcSEcCtD
Disopyramide—Shock—Bupropion—obesity	0.000121	0.00134	CcSEcCtD
Disopyramide—Pain—Sibutramine—obesity	0.000121	0.00133	CcSEcCtD
Disopyramide—Constipation—Sibutramine—obesity	0.000121	0.00133	CcSEcCtD
Disopyramide—Thrombocytopenia—Bupropion—obesity	0.00012	0.00133	CcSEcCtD
Disopyramide—Feeling abnormal—Orlistat—obesity	0.00012	0.00133	CcSEcCtD
Disopyramide—Skin disorder—Bupropion—obesity	0.000119	0.00132	CcSEcCtD
Disopyramide—Hyperhidrosis—Bupropion—obesity	0.000119	0.00131	CcSEcCtD
Disopyramide—Anorexia—Bupropion—obesity	0.000117	0.0013	CcSEcCtD
Disopyramide—Feeling abnormal—Sibutramine—obesity	0.000116	0.00129	CcSEcCtD
Disopyramide—Urticaria—Orlistat—obesity	0.000116	0.00128	CcSEcCtD
Disopyramide—Body temperature increased—Orlistat—obesity	0.000115	0.00127	CcSEcCtD
Disopyramide—Hypotension—Bupropion—obesity	0.000115	0.00127	CcSEcCtD
Disopyramide—Agranulocytosis—Topiramate—obesity	0.000115	0.00127	CcSEcCtD
Disopyramide—Bradycardia—Topiramate—obesity	0.000112	0.00124	CcSEcCtD
Disopyramide—Urticaria—Sibutramine—obesity	0.000112	0.00124	CcSEcCtD
Disopyramide—Body temperature increased—Sibutramine—obesity	0.000112	0.00123	CcSEcCtD
Disopyramide—Insomnia—Bupropion—obesity	0.000111	0.00123	CcSEcCtD
Disopyramide—Paraesthesia—Bupropion—obesity	0.00011	0.00122	CcSEcCtD
Disopyramide—Hepatitis—Topiramate—obesity	0.00011	0.00122	CcSEcCtD
Disopyramide—Hypoaesthesia—Topiramate—obesity	0.00011	0.00121	CcSEcCtD
Disopyramide—Dyspnoea—Bupropion—obesity	0.00011	0.00121	CcSEcCtD
Disopyramide—Somnolence—Bupropion—obesity	0.000109	0.00121	CcSEcCtD
Disopyramide—Dyspepsia—Bupropion—obesity	0.000108	0.0012	CcSEcCtD
Disopyramide—Decreased appetite—Bupropion—obesity	0.000107	0.00118	CcSEcCtD
Disopyramide—Fatigue—Bupropion—obesity	0.000106	0.00117	CcSEcCtD
Disopyramide—Pain—Bupropion—obesity	0.000105	0.00116	CcSEcCtD
Disopyramide—Constipation—Bupropion—obesity	0.000105	0.00116	CcSEcCtD
Disopyramide—Asthenia—Orlistat—obesity	0.000105	0.00116	CcSEcCtD
Disopyramide—Pruritus—Orlistat—obesity	0.000103	0.00114	CcSEcCtD
Disopyramide—Feeling abnormal—Bupropion—obesity	0.000101	0.00112	CcSEcCtD
Disopyramide—Asthenia—Sibutramine—obesity	0.000101	0.00112	CcSEcCtD
Disopyramide—Pruritus—Sibutramine—obesity	9.98e-05	0.0011	CcSEcCtD
Disopyramide—Diarrhoea—Orlistat—obesity	9.98e-05	0.0011	CcSEcCtD
Disopyramide—Urticaria—Bupropion—obesity	9.77e-05	0.00108	CcSEcCtD
Disopyramide—Body temperature increased—Bupropion—obesity	9.72e-05	0.00107	CcSEcCtD
Disopyramide—Diarrhoea—Sibutramine—obesity	9.65e-05	0.00107	CcSEcCtD
Disopyramide—Dizziness—Orlistat—obesity	9.64e-05	0.00107	CcSEcCtD
Disopyramide—Flatulence—Topiramate—obesity	9.46e-05	0.00105	CcSEcCtD
Disopyramide—Tension—Topiramate—obesity	9.42e-05	0.00104	CcSEcCtD
Disopyramide—Dysgeusia—Topiramate—obesity	9.4e-05	0.00104	CcSEcCtD
Disopyramide—Dizziness—Sibutramine—obesity	9.33e-05	0.00103	CcSEcCtD
Disopyramide—Nervousness—Topiramate—obesity	9.33e-05	0.00103	CcSEcCtD
Disopyramide—Vomiting—Orlistat—obesity	9.27e-05	0.00102	CcSEcCtD
Disopyramide—Rash—Orlistat—obesity	9.19e-05	0.00102	CcSEcCtD
Disopyramide—Dermatitis—Orlistat—obesity	9.18e-05	0.00102	CcSEcCtD
Disopyramide—Headache—Orlistat—obesity	9.13e-05	0.00101	CcSEcCtD
Disopyramide—Vision blurred—Topiramate—obesity	9.05e-05	0.001	CcSEcCtD
Disopyramide—Vomiting—Sibutramine—obesity	8.97e-05	0.000992	CcSEcCtD
Disopyramide—Ill-defined disorder—Topiramate—obesity	8.91e-05	0.000985	CcSEcCtD
Disopyramide—Rash—Sibutramine—obesity	8.9e-05	0.000983	CcSEcCtD
Disopyramide—Dermatitis—Sibutramine—obesity	8.89e-05	0.000982	CcSEcCtD
Disopyramide—Headache—Sibutramine—obesity	8.84e-05	0.000977	CcSEcCtD
Disopyramide—Asthenia—Bupropion—obesity	8.83e-05	0.000975	CcSEcCtD
Disopyramide—Pruritus—Bupropion—obesity	8.7e-05	0.000962	CcSEcCtD
Disopyramide—Nausea—Orlistat—obesity	8.66e-05	0.000957	CcSEcCtD
Disopyramide—Malaise—Topiramate—obesity	8.66e-05	0.000957	CcSEcCtD
Disopyramide—Vertigo—Topiramate—obesity	8.63e-05	0.000953	CcSEcCtD
Disopyramide—Syncope—Topiramate—obesity	8.61e-05	0.000952	CcSEcCtD
Disopyramide—Loss of consciousness—Topiramate—obesity	8.44e-05	0.000933	CcSEcCtD
Disopyramide—Diarrhoea—Bupropion—obesity	8.42e-05	0.00093	CcSEcCtD
Disopyramide—Nausea—Sibutramine—obesity	8.38e-05	0.000926	CcSEcCtD
Disopyramide—Chest pain—Topiramate—obesity	8.17e-05	0.000904	CcSEcCtD
Disopyramide—Dizziness—Bupropion—obesity	8.13e-05	0.000899	CcSEcCtD
Disopyramide—Discomfort—Topiramate—obesity	8.08e-05	0.000893	CcSEcCtD
Disopyramide—Dry mouth—Topiramate—obesity	7.99e-05	0.000884	CcSEcCtD
Disopyramide—Confusional state—Topiramate—obesity	7.9e-05	0.000873	CcSEcCtD
Disopyramide—Oedema—Topiramate—obesity	7.84e-05	0.000866	CcSEcCtD
Disopyramide—Vomiting—Bupropion—obesity	7.82e-05	0.000864	CcSEcCtD
Disopyramide—Rash—Bupropion—obesity	7.76e-05	0.000857	CcSEcCtD
Disopyramide—Dermatitis—Bupropion—obesity	7.75e-05	0.000856	CcSEcCtD
Disopyramide—Shock—Topiramate—obesity	7.71e-05	0.000852	CcSEcCtD
Disopyramide—Headache—Bupropion—obesity	7.71e-05	0.000852	CcSEcCtD
Disopyramide—Thrombocytopenia—Topiramate—obesity	7.67e-05	0.000848	CcSEcCtD
Disopyramide—Skin disorder—Topiramate—obesity	7.61e-05	0.000841	CcSEcCtD
Disopyramide—Hyperhidrosis—Topiramate—obesity	7.58e-05	0.000837	CcSEcCtD
Disopyramide—Anorexia—Topiramate—obesity	7.47e-05	0.000826	CcSEcCtD
Disopyramide—Hypotension—Topiramate—obesity	7.32e-05	0.000809	CcSEcCtD
Disopyramide—Nausea—Bupropion—obesity	7.31e-05	0.000808	CcSEcCtD
Disopyramide—Insomnia—Topiramate—obesity	7.09e-05	0.000783	CcSEcCtD
Disopyramide—Paraesthesia—Topiramate—obesity	7.04e-05	0.000778	CcSEcCtD
Disopyramide—Dyspnoea—Topiramate—obesity	6.99e-05	0.000772	CcSEcCtD
Disopyramide—Somnolence—Topiramate—obesity	6.97e-05	0.00077	CcSEcCtD
Disopyramide—Dyspepsia—Topiramate—obesity	6.9e-05	0.000762	CcSEcCtD
Disopyramide—Decreased appetite—Topiramate—obesity	6.81e-05	0.000753	CcSEcCtD
Disopyramide—Fatigue—Topiramate—obesity	6.76e-05	0.000747	CcSEcCtD
Disopyramide—Pain—Topiramate—obesity	6.7e-05	0.000741	CcSEcCtD
Disopyramide—Constipation—Topiramate—obesity	6.7e-05	0.000741	CcSEcCtD
Disopyramide—Feeling abnormal—Topiramate—obesity	6.46e-05	0.000714	CcSEcCtD
Disopyramide—Urticaria—Topiramate—obesity	6.23e-05	0.000688	CcSEcCtD
Disopyramide—Body temperature increased—Topiramate—obesity	6.19e-05	0.000685	CcSEcCtD
Disopyramide—Asthenia—Topiramate—obesity	5.62e-05	0.000621	CcSEcCtD
Disopyramide—Pruritus—Topiramate—obesity	5.54e-05	0.000613	CcSEcCtD
Disopyramide—Diarrhoea—Topiramate—obesity	5.36e-05	0.000593	CcSEcCtD
Disopyramide—Dizziness—Topiramate—obesity	5.18e-05	0.000573	CcSEcCtD
Disopyramide—Vomiting—Topiramate—obesity	4.98e-05	0.000551	CcSEcCtD
Disopyramide—Rash—Topiramate—obesity	4.94e-05	0.000546	CcSEcCtD
Disopyramide—Dermatitis—Topiramate—obesity	4.94e-05	0.000546	CcSEcCtD
Disopyramide—Headache—Topiramate—obesity	4.91e-05	0.000543	CcSEcCtD
Disopyramide—Nausea—Topiramate—obesity	4.65e-05	0.000514	CcSEcCtD
Disopyramide—CHRM2—Signaling by GPCR—RHOA—obesity	3.21e-06	5.36e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3R1—obesity	3.21e-06	5.36e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNAS—obesity	3.2e-06	5.34e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARA—obesity	3.19e-06	5.32e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3R1—obesity	3.18e-06	5.31e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CG—obesity	3.17e-06	5.3e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOB—obesity	3.17e-06	5.29e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOB—obesity	3.16e-06	5.28e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ACP5—obesity	3.13e-06	5.23e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOB—obesity	3.13e-06	5.23e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL5—obesity	3.1e-06	5.17e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AGT—obesity	3.09e-06	5.16e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL5—obesity	3.09e-06	5.15e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—obesity	3.06e-06	5.11e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL5—obesity	3.06e-06	5.1e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—G6PD—obesity	3.05e-06	5.09e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LPL—obesity	3.03e-06	5.06e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOE—obesity	3.03e-06	5.05e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—POMC—obesity	3.02e-06	5.04e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LPL—obesity	3.02e-06	5.04e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HK1—obesity	3.01e-06	5.03e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SREBF2—obesity	3.01e-06	5.03e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FOXO1—obesity	3.01e-06	5.02e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—INS—obesity	3e-06	5.01e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RPS6KB1—obesity	3e-06	5.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CAV1—obesity	3e-06	5.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FOXO1—obesity	3e-06	5e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RPS6KB1—obesity	2.99e-06	4.99e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOA1—obesity	2.99e-06	4.99e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LPL—obesity	2.99e-06	4.99e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CB—obesity	2.97e-06	4.96e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FOXO1—obesity	2.97e-06	4.95e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RPS6KB1—obesity	2.96e-06	4.95e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CB—obesity	2.96e-06	4.95e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CG—obesity	2.96e-06	4.94e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CB—obesity	2.93e-06	4.9e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPA—obesity	2.91e-06	4.86e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—obesity	2.85e-06	4.76e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPIN1—obesity	2.85e-06	4.76e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—POMC—obesity	2.81e-06	4.7e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—INS—obesity	2.8e-06	4.67e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOA5—obesity	2.79e-06	4.66e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKCD—obesity	2.79e-06	4.66e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CD—obesity	2.79e-06	4.66e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKCD—obesity	2.78e-06	4.64e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKCD—obesity	2.75e-06	4.6e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—obesity	2.75e-06	4.6e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CG—obesity	2.73e-06	4.56e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR2A—obesity	2.73e-06	4.56e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—C3—obesity	2.73e-06	4.55e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR2A—obesity	2.72e-06	4.54e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—C3—obesity	2.72e-06	4.54e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR2A—obesity	2.69e-06	4.5e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—C3—obesity	2.69e-06	4.49e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CLOCK—obesity	2.66e-06	4.45e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC22A1—obesity	2.66e-06	4.45e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—obesity	2.64e-06	4.4e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3R1—obesity	2.63e-06	4.4e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NOS3—obesity	2.63e-06	4.4e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—POMC—obesity	2.6e-06	4.34e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CD—obesity	2.6e-06	4.34e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GLP1R—obesity	2.59e-06	4.33e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SULT2A1—obesity	2.59e-06	4.33e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IRS2—obesity	2.59e-06	4.33e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AGT—obesity	2.59e-06	4.33e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IRS2—obesity	2.59e-06	4.32e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—INS—obesity	2.58e-06	4.32e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AGT—obesity	2.58e-06	4.31e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—obesity	2.57e-06	4.28e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IRS2—obesity	2.56e-06	4.27e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AGT—obesity	2.56e-06	4.27e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—DPYD—obesity	2.55e-06	4.26e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOE—obesity	2.54e-06	4.24e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LEP—obesity	2.54e-06	4.24e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOE—obesity	2.53e-06	4.22e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LEP—obesity	2.53e-06	4.22e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CAV1—obesity	2.51e-06	4.2e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOA1—obesity	2.51e-06	4.19e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CAV1—obesity	2.51e-06	4.19e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LEP—obesity	2.51e-06	4.18e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOE—obesity	2.51e-06	4.18e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOA1—obesity	2.5e-06	4.18e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CAV1—obesity	2.48e-06	4.14e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOA1—obesity	2.48e-06	4.14e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PRKAR2B—obesity	2.46e-06	4.1e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NOS3—obesity	2.45e-06	4.1e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3R1—obesity	2.45e-06	4.1e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—DCN—obesity	2.44e-06	4.07e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CB—obesity	2.43e-06	4.06e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ESR1—obesity	2.42e-06	4.05e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ESR1—obesity	2.42e-06	4.03e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—obesity	2.41e-06	4.02e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CD—obesity	2.4e-06	4.01e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—F2—obesity	2.39e-06	4e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKCB—obesity	2.39e-06	4e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ESR1—obesity	2.39e-06	3.99e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—F2—obesity	2.39e-06	3.98e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKCB—obesity	2.39e-06	3.98e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CPT1A—obesity	2.37e-06	3.96e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—obesity	2.37e-06	3.96e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BAD—obesity	2.37e-06	3.95e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—F2—obesity	2.36e-06	3.95e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKCB—obesity	2.36e-06	3.95e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BAD—obesity	2.36e-06	3.94e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BAD—obesity	2.33e-06	3.9e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NAMPT—obesity	2.33e-06	3.89e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LIPC—obesity	2.31e-06	3.86e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCK—obesity	2.31e-06	3.86e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOC3—obesity	2.3e-06	3.84e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CG—obesity	2.29e-06	3.82e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CG—obesity	2.28e-06	3.81e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3R1—obesity	2.27e-06	3.78e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NOS3—obesity	2.27e-06	3.78e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CB—obesity	2.27e-06	3.78e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IRS1—obesity	2.26e-06	3.78e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CG—obesity	2.26e-06	3.78e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IRS1—obesity	2.26e-06	3.77e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—obesity	2.24e-06	3.75e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IRS1—obesity	2.24e-06	3.73e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CETP—obesity	2.23e-06	3.73e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SDC1—obesity	2.21e-06	3.68e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—POMC—obesity	2.18e-06	3.64e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—POMC—obesity	2.17e-06	3.63e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKR1C3—obesity	2.17e-06	3.62e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—INS—obesity	2.17e-06	3.62e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—INS—obesity	2.16e-06	3.61e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—POMC—obesity	2.15e-06	3.59e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—INS—obesity	2.14e-06	3.57e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SCARB1—obesity	2.14e-06	3.57e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL2—obesity	2.13e-06	3.56e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL2—obesity	2.13e-06	3.55e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL2—obesity	2.11e-06	3.52e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1—obesity	2.1e-06	3.5e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT2—obesity	2.1e-06	3.5e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CB—obesity	2.09e-06	3.49e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1—obesity	2.09e-06	3.49e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT2—obesity	2.09e-06	3.49e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SREBF1—obesity	2.07e-06	3.46e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—obesity	2.07e-06	3.46e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1—obesity	2.07e-06	3.46e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT2—obesity	2.07e-06	3.45e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GOT2—obesity	2.02e-06	3.37e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CD—obesity	2.01e-06	3.36e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CD—obesity	2.01e-06	3.35e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CA—obesity	1.99e-06	3.33e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SERPINE1—obesity	1.99e-06	3.33e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CA—obesity	1.99e-06	3.32e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CD—obesity	1.99e-06	3.32e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SERPINE1—obesity	1.99e-06	3.31e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—FASN—obesity	1.97e-06	3.3e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CA—obesity	1.97e-06	3.29e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—BCHE—obesity	1.97e-06	3.28e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SERPINE1—obesity	1.97e-06	3.28e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TYK2—obesity	1.94e-06	3.23e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TYK2—obesity	1.93e-06	3.22e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RHOA—obesity	1.92e-06	3.21e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RHOA—obesity	1.92e-06	3.2e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TYK2—obesity	1.91e-06	3.19e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3R1—obesity	1.9e-06	3.17e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOS3—obesity	1.9e-06	3.17e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2E1—obesity	1.9e-06	3.17e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RHOA—obesity	1.9e-06	3.17e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3R1—obesity	1.9e-06	3.16e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOS3—obesity	1.9e-06	3.16e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3R1—obesity	1.88e-06	3.13e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOS3—obesity	1.88e-06	3.13e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NQO1—obesity	1.88e-06	3.13e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CA—obesity	1.81e-06	3.02e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CA—obesity	1.81e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A4—obesity	1.8e-06	3e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCG—obesity	1.8e-06	3e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CA—obesity	1.79e-06	2.99e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYCS—obesity	1.77e-06	2.96e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MTOR—obesity	1.76e-06	2.93e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CB—obesity	1.76e-06	2.93e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MTOR—obesity	1.75e-06	2.92e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CB—obesity	1.75e-06	2.92e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GOT1—obesity	1.74e-06	2.91e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GGT1—obesity	1.74e-06	2.91e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CB—obesity	1.73e-06	2.89e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MTOR—obesity	1.73e-06	2.89e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NCOA1—obesity	1.72e-06	2.86e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP19A1—obesity	1.69e-06	2.82e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—STK11—obesity	1.69e-06	2.82e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—obesity	1.63e-06	2.72e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—obesity	1.62e-06	2.71e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—obesity	1.61e-06	2.69e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—obesity	1.6e-06	2.68e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—obesity	1.6e-06	2.67e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—obesity	1.58e-06	2.64e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—COMT—obesity	1.57e-06	2.62e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARGC1A—obesity	1.55e-06	2.59e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GNB3—obesity	1.55e-06	2.59e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—obesity	1.54e-06	2.58e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—obesity	1.53e-06	2.55e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—obesity	1.52e-06	2.54e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GNAS—obesity	1.51e-06	2.52e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—obesity	1.51e-06	2.51e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK8—obesity	1.48e-06	2.48e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CA—obesity	1.48e-06	2.47e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—obesity	1.48e-06	2.47e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK8—obesity	1.48e-06	2.47e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOB—obesity	1.48e-06	2.47e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—obesity	1.47e-06	2.46e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK8—obesity	1.46e-06	2.45e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—obesity	1.46e-06	2.44e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPL—obesity	1.41e-06	2.36e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CA—obesity	1.38e-06	2.31e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPX1—obesity	1.38e-06	2.3e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STAT3—obesity	1.36e-06	2.26e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STAT3—obesity	1.35e-06	2.26e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CD36—obesity	1.34e-06	2.24e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STAT3—obesity	1.34e-06	2.24e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CA—obesity	1.28e-06	2.13e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTHFR—obesity	1.27e-06	2.12e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—obesity	1.26e-06	2.1e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFB1—obesity	1.26e-06	2.1e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—obesity	1.26e-06	2.1e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFB1—obesity	1.25e-06	2.09e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARA—obesity	1.25e-06	2.08e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—obesity	1.24e-06	2.08e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFB1—obesity	1.24e-06	2.07e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—obesity	1.21e-06	2.02e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AGT—obesity	1.21e-06	2.02e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOE—obesity	1.18e-06	1.97e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAV1—obesity	1.17e-06	1.96e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOA1—obesity	1.17e-06	1.95e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—obesity	1.13e-06	1.88e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CA—obesity	1.07e-06	1.79e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CG—obesity	1.07e-06	1.78e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CA—obesity	1.07e-06	1.78e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CA—obesity	1.06e-06	1.76e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—obesity	1.04e-06	1.74e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—obesity	1.03e-06	1.72e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—POMC—obesity	1.02e-06	1.7e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—INS—obesity	1.01e-06	1.69e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—obesity	9.47e-07	1.58e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—obesity	9.44e-07	1.58e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CD—obesity	9.38e-07	1.57e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—obesity	9.35e-07	1.56e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—obesity	9.26e-07	1.55e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NOS3—obesity	8.86e-07	1.48e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3R1—obesity	8.86e-07	1.48e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—obesity	8.74e-07	1.46e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—obesity	8.71e-07	1.45e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—obesity	8.63e-07	1.44e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CB—obesity	8.18e-07	1.37e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—obesity	8.1e-07	1.35e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CA—obesity	4.99e-07	8.33e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—obesity	4.07e-07	6.8e-06	CbGpPWpGaD
